This news update featuring Dr Reddy’s Laboratories is brought to you by firstbiz.
Drugmaker Dr Reddy’s Laboratories has come under the scanner of Department of Justice of USA for alleged violations of some provisions of Consumer Product Safety Act involving child resistant packaging regulations.
The company has denied the Consumer Product Safety Commission’s (CPSC) allegations in the matter.
The Indian drug major said in a filing with US Securities and Exchange Commission (SEC) that the issue is related to compliance with requirements of special packaging for child resistant blister packs for six products sold by the company in the United States from 2002 through 2011.
For more information on Dr Reddy’s Laboratories, please visit the firstbiz link above. Please contact Nexreg for Label Services.